These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 9441324
21. Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases. Arda B, Yamazhan T, Sipahi OR, Islekel S, Buke C, Ulusoy S. Int J Antimicrob Agents; 2005 May; 25(5):414-8. PubMed ID: 15848297 [Abstract] [Full Text] [Related]
22. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G. Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849 [Abstract] [Full Text] [Related]
23. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus. Nagura J, Kijima K, Kurazono M, Takahata S, Sugano T, Tanaka Y, Hirai Y, Yamada K, Takayama Y, Shitara E, Yonezawa M. Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975 [Abstract] [Full Text] [Related]
24. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis]. Jourdan C, Convert J, Peloux A, Boussaid O, Grando J, Tigaud S. Pathol Biol (Paris); 1996 May; 44(5):389-92. PubMed ID: 8758482 [Abstract] [Full Text] [Related]
25. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone. Siaperas P, Pefanis A, Iliopoulos D, Katsarolis I, Kyroudi-Voulgari A, Donta I, Karayiannakos P, Giamarellou H. Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335 [Abstract] [Full Text] [Related]
26. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis. Pavie J, Lefort A, Ploy MC, Massias L, Chau F, Garry L, Denis F, Fantin B. Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890 [Abstract] [Full Text] [Related]
27. [Methicillin-resistant Staphylococcus aureus infection in a geriatric unit for acutely ill]. Selva O'Callaghan A, San José Laporte A, Almirante Gragera B, Vilardell Tarrés M. Med Clin (Barc); 1998 May 16; 110(17):678. PubMed ID: 9656216 [No Abstract] [Full Text] [Related]
28. [Glycopeptides (vancomycin, teicoplanin)--their place in the antibacterial therapy of patients in a high-risk group]. Beloborodova NV. Anesteziol Reanimatol; 1998 May 16; (4):23-7. PubMed ID: 9770813 [Abstract] [Full Text] [Related]
30. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. Gudiol F, Aguado JM, Pascual A, Pujol M, Almirante B, Miró JM, Cercenado E, Domínguez Mde L, Soriano A, Rodríguez-Baño J, Vallés J, Palomar M, Tornos P, Bouza E, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Enferm Infecc Microbiol Clin; 2009 Feb 15; 27(2):105-15. PubMed ID: 19254641 [Abstract] [Full Text] [Related]
31. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci]. Pham Dang C, Gouin F, Touchais S, Richard C, Potel G. Pathol Biol (Paris); 2001 Sep 15; 49(7):587-96. PubMed ID: 11642024 [Abstract] [Full Text] [Related]
32. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections. Kitzis MD, Goldstein FW. Clin Microbiol Infect; 2006 Jan 15; 12(1):92-5. PubMed ID: 16460555 [Abstract] [Full Text] [Related]
33. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. Vouillamoz J, Moreillon P, Giddey M, Entenza JM. J Antimicrob Chemother; 2006 Dec 15; 58(6):1208-14. PubMed ID: 17030515 [Abstract] [Full Text] [Related]
34. The role of vancomycin in the treatment paradigm. Stevens DL. Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S51-7. PubMed ID: 16323121 [Abstract] [Full Text] [Related]
35. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates]. Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S. Mikrobiyol Bul; 2007 Oct 01; 41(4):511-6. PubMed ID: 18173069 [Abstract] [Full Text] [Related]
36. Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia. Lin SH, Lai CC, Tan CK, Liao WH, Hsueh PR. Int J Antimicrob Agents; 2011 Feb 01; 37(2):179-81. PubMed ID: 21163634 [No Abstract] [Full Text] [Related]
37. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Micek ST. Clin Infect Dis; 2007 Sep 15; 45 Suppl 3():S184-90. PubMed ID: 17712745 [Abstract] [Full Text] [Related]
38. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents]. Ertek M, Yazgi H, Aktaş E, Ayyildiz A, Parlak M. Mikrobiyol Bul; 2003 Oct 15; 37(4):235-40. PubMed ID: 14748259 [Abstract] [Full Text] [Related]
39. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Woods CW, Cheng AC, Fowler VG, Moorefield M, Frederick J, Sakoulas G, Meka VG, Tenover FC, Zwadyk P, Wilson KH. Clin Infect Dis; 2004 Apr 15; 38(8):1188-91. PubMed ID: 15095227 [Abstract] [Full Text] [Related]
40. Possible synergy between aminoglycosides and vancomycin in the treatment of Staphylococcus epidermidis endocarditis? Plastino KA, Connors JE, Spinler SA. Ann Pharmacother; 1994 Jun 15; 28(6):737-9. PubMed ID: 7919563 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]